No one can say whether that will happen next year, but even if it doesn't, there are plenty of companies that can deliver excellent returns despite heightened market volatility and a struggling economy. Let's consider two examples: Eli Lilly (NYSE: LLY) and Visa (NYSE: V). Pharma giant Eli Lilly has been flying high all year despite its financial results not being particularly impressive.
From health insurance to life-saving medical treatments, healthcare is a sector that the world literally can't live without. Let's take a look at two well-established healthcare stocks that have made investors much richer in recent years and appear poised to do well moving forward. With over 37,000 employees and products sold in more than 120 countries, Eli Lilly (NYSE: LLY) is among the largest pharmaceutical companies in the world.
Pfizer (PFE) and Roivant Sciences (ROIV) form a new Roivant subsidiary to develop an inflammatory disease drug. AstraZeneca (AZN) to boost cell therapies portfolio with private company buyout.